J. Porter

Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective

Richard B. Lipton, Alan Brennan, Stephen Palmer et al. · Journal of Medical Economics · 2018 · 63 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials

J. Porter, Gian Luca Di Tanna, Richard B. Lipton et al. · PharmacoEconomics - Open · 2018 · 45 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe

Dawn Lee, Daniel Gladwell, Anthony J. Hatswell et al. · Health Economics Review · 2014 · 19 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17

Reducing Drug Wastage in Pharmaceuticals Dosed by Weight or Body Surface Areas by Optimising Vial Sizes

Anthony J. Hatswell, J. Porter · Applied Health Economics and Health Policy · 2018 · 19 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16

Characteristics and outcomes of children ≤ 10 kg receiving continuous kidney replacement therapy: a WE-ROCK study

Shina Menon, Michelle C. Starr, Huaiyu Zang et al. · Pediatric Nephrology · 2024 · 19 citations · Full text

Medicine, Nephrology, Pediatrics +14